Nanozyme-SERS technology has shown promise in disease diagnosis by detecting compounds such as H2O2, uric acid (UA), glutathione (GSH), cholesterol, alpha-fetoprotein (AFP), and carcinoembryonic antigen (CEA) in serum, which are indicative of various disorders and cancers. Here, CEACAM5 is linked to cancer.